ERBB2 and neoplasm: In vivo imaging of the fluorescent conjugate depicted clear tumor localization in low HER2‐expressing FaDu xenografts at 72 h post‐injection, while no tumor‐specific fluorescence was seen in mice with UMSCC‐1 xenografts which lack HER2 expression.